南太平洋水下医学会（SPUMS）和英国潜水医学委员会（UKDMC）2024年关于浸没性肺水肿与潜水的联合立场声明。
Joint position statement on immersion pulmonary oedema and diving from the South Pacific Underwater Medicine Society (SPUMS) and the United Kingdom Diving Medical Committee (UKDMC) 2024.
作者信息
Banham Neil, Smart David, Wilmshurst Peter, Mitchell Simon J, Turner Mark S, Bryson Philip
机构信息
Department of Hyperbaric Medicine, Fiona Stanley Hospital, Perth, Australia.
Corresponding author: Dr Neil Banham, Department of Hyperbaric Medicine, Fiona Stanley Hospital, 11 Robin Warren Drive, Murdoch WA 6150, Australia,
出版信息
Diving Hyperb Med. 2024 Dec 20;54(4):344-349. doi: 10.28920/dhm54.4.344-349.
This joint position statement (JPS) on immersion pulmonary oedema (IPO) and diving is the product of a workshop held at the 52nd Annual Scientific Meeting of the South Pacific Underwater Medicine Society (SPUMS) from 12-17 May 2024, and consultation with the United Kingdom Diving Medical Committee (UKDMC), three members of which attended the meeting. The JPS is a consensus of experts with relevant evidence cited where available. The statement reviews the nomenclature, pathophysiology, risk factors, clinical features, prehospital treatment, investigation of and the fitness for future compressed gas diving following an episode of IPO. Immersion pulmonary oedema is a life-threatening illness that requires emergency management as described in this statement. A diver with previous suspected or confirmed IPO should consult a medical practitioner experienced in diving medicine. The SPUMS and the UKDMC strongly advise against further compressed gas diving if an individual has experienced an episode of IPO.
这份关于浸没性肺水肿（IPO）与潜水的联合立场声明（JPS），是在2024年5月12日至17日举行的南太平洋水下医学会（SPUMS）第52届年度科学会议上举办的一次研讨会的成果，并与英国潜水医学委员会（UKDMC）进行了磋商，该委员会的三名成员出席了会议。该联合立场声明是专家们的共识，并在可行之处引用了相关证据。本声明回顾了IPO发作后的命名法、病理生理学、危险因素、临床特征、院前治疗、调查以及未来进行压缩气体潜水的适用性。浸没性肺水肿是一种危及生命的疾病，需要按照本声明所述进行紧急处理。曾有疑似或确诊IPO病史的潜水员应咨询有潜水医学经验的医生。南太平洋水下医学会和英国潜水医学委员会强烈建议，若个人曾经历过IPO发作，则不要进行进一步的压缩气体潜水。
Zotero 插件